SCHEMBL2402247

SCHEMBL2402247

C[N][C@H](C)c1ccccc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.48
ACHE P22303 2/20 0.41
TSHR P16473 1/20 0.41
ACP3 P15309 1/20 0.37
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
GAA P10253 1/20 0.35
ADRA2A P08913 2/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 1/20 0.35
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34
ALDH1A1 P00352 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
ADRB2 P07550 1/20 0.33
CYP2D6 P10635 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14647655 0.75 ESR1 (0.52) ESR1ACHETSHRACP3SLC6A2
SCHEMBL2404367 0.74 HSD11B1 (0.44) ACHEGAAGABRA1GABRB2ALDH1A1
SCHEMBL2400168 0.74 HSD11B1 (0.44) TSHRSLC6A2GABRA1GABRB2ALDH1A1
SCHEMBL2400751 0.74 HSD11B1 (0.44) TSHRSLC6A2SLC6A4SLC6A3ADRA2A
SCHEMBL4199089 0.74 GABRA1 (0.60) TSHRSLC6A2GAAGABRA1GABRB2
SCHEMBL16308866 0.74 ESR1 (0.47) ESR1ACHETSHRACP3SLC6A2
SCHEMBL8755636 0.74 ESR1 (0.42) ESR1ACHETSHRACP3SLC6A2
SCHEMBL19449790 0.74 ESR1 (0.47) ESR1ACHETSHRACP3SLC6A2
SCHEMBL5493731 0.74 ESR1 (0.56) ESR1ACHETSHRACP3SLC6A2
SCHEMBL29392590 0.74 ESR1 (0.56) ESR1ACHETSHRACP3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835427-B2 Fungicidal heterocyclic compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2014-09-16 US disclosed
EP-2358709-B1 FUNGICIDAL HETEROCYCLIC COMPOUNDS DU PONT (US) 2014-01-22 EP disclosed
US-8618137-B2 Fungicidal heterocyclic compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2013-12-31 US disclosed
US-20120309752-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E I DU PONT DE NEMOURS AND COMPANY (US) 2012-12-06 US disclosed
US-20110224258-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (DE) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224258-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS NOX1, XDH, CBR1 ESR1 3154/4885ACHE 464/4885TSHR 2864/4885
US-20120309752-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS CYP1B1, NOX3, CYP1A1 ESR1 1934/4885ACHE 605/4885TSHR 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.